Skip to main content

Table 3 Effect of health partnership program

From: A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors

   Unadjusted estimates, mean (SD) Adjusted analysis for intervention vs usual carea
Intervention group Control group Intervention group Control group P value1)
MET/h/day Baseline 26.7 (27.5) 27.5 (19.8)    
3 months 27.1 (25.4) 24.3 (24.6) 26.2 (2.2) 23.9 (3.0) 0.540
12 months 23.5 (23.6) 22.9 (24.6) 22.9 (2.3) 22.8 (3.3) 0.975
PTGI-Total Baseline 63.1 (18.5) 61.8 (18.9)    
3 months 63.6 (19.3) 61.2 (18.6) 62.7 (1.3) 62.1 (1.7) 0.791
12 months 66.6 (19.3) 60.2 (19.1) 66.3 (1.6) 61.2 (2.2) 0.065*
Vegetable intake n(%), ≥5 serves/day Baseline 45 (33.6) 22 (30.6)    
3 months 52 (42.6) 27 (40.9) 33.6 (4.9) 31.0 (6.3) 0.819
12 months 41 (36.9) 26 (42.6) 31.0 (5.4) 37.3 (6.7) 0.413
Leadership Baseline 121.3 (21.2) 120.1 (20.8)    
3 months 125.0 (21.7) 121.6 (20.2) 123.1 (1.3) 121.8 (1.9) 0.552
12 months 127.7 (22.1) 122.8 (20.6) 125.4 (1.6) 123.3 (2.2) 0.433
HADS
 Anxiety Baseline 5.7 (3.4) 5.9 (3.1)    
3 months 5.0 (3.0) 6.1 (3.1) 5.2 (0.2) 6.0 (0.3) 0.025**
12 months 5.1 (3.0) 5.8 (2.9) 5.2 (0.3) 5.7 (0.4) 0.228
 Depression Baseline 6.4 (3.5) 6.1 (3.1)    
3 months 5.5 (3.3) 5.4 (2.8) 5.6 (0.2) 5.6 (0.3) 0.986
12 months 5.4 (3.4) 5.6 (3.1) 5.3 (0.3) 5.7 (0.4) 0.428
EORTC QLQ-C30
 Functional scales
  Global health status Baseline 64.5 (19.9) 63.4 (18.7)    
3 months 67.7 (18.7) 65.7 (17.5) 67.0 (1.6) 66.0 (2.3) 0.705
12 months 70.1 (17.1) 65.3 (17.9) 69.0 (1.6) 66.0 (2.2) 0.269
  Physical functioning Baseline 78.6 (13.5) 77.9 (11.1)    
3 months 80.0 (12.1) 78.4 (12.0) 79.4 (0.9) 79.3 (1.3) 0.942
12 months 82.9 (13.1) 78.2 (12.4) 81.9 (1.2) 78.7 (1.6) 0.123
  Role functioning Baseline 79.4 (21.4) 77.9 (19.8)    
3 months 80.9 (18.1) 77.3 (18.4) 80.3 (1.5) 78.5 (2.2) 0.497
12 months 82.7 (19.8) 79.9 (18.9) 80.9 (1.8) 81.1 (2.4) 0.958
  Emotional functioning Baseline 76.8 (19.4) 73.0 (23.0)    
3 months 78.0 (19.1) 74.5 (16.5) 76.7 (1.5) 75.3 (2.2) 0.602
12 months 78.0 (19.9) 75.9 (18.3) 76.2 (1.9) 77.7 (2.4) 0.625
  Cognitive functioning Baseline 76.7 (19.9) 72.6 (20.9)    
3 months 80.1 (17.2) 72.5 (20.2) 77.6 (1.4) 75.1 (2.4) 0.322
12 months 78.1 (14.9) 76.5 (19.2) 76.8 (1.6) 78.4 (2.1) 0.552
  Social functioning Baseline 75.8 (26.8) 73.1 (23.4)    
3 months 85.4 (19.3) 76.3 (20.2) 84.8 (1.8) 77.4 (2.5) 0.018
12 months 85.3 (19.5) 78.2 (22.4) 84.8 (2.2) 79.0 (2.9) 0.123
 Symptom scales
  Fatigue Baseline 38.6 (20.9) 40.8 (21.6)    
3 months 33.5 (17.8) 38.1 (17.7) 34.3 (1.5) 37.6 (2.2) 0.214
12 months 33.8 (16.1) 42.4 (21.4) 34.8 (1.6) 41.9 (2.1) 0.010**
  Nausea/vomiting Baseline 4.6 (10.0) 4.2 (10.6)    
3 months 5.7 (10.6) 5.3 (9.8) 5.6 (0.9) 6.2 (1.3) 0.733
12 months 6.4 (14.5) 7.8 (15.3) 6.5 (1.6) 7.7 (2.1) 0.660
  Pain Baseline 15.4 (19.2) 21.4 (19.0)    
3 months 11.9 (16.0) 19.6 (19.6) 13.6 (1.5) 17.4 (2.1) 0.146
12 months 13.1 (17.6) 19.7 (21.4) 15.5 (1.8) 16.2 (2.3) 0.810
  Dyspnea Baseline 11.9 (19.9) 19.4 (21.0)    
3 months 8.2 (15.9) 13.7 (16.6) 10.3 (1.3) 11.3 (1.9) 0.668
12 months 10.6 (19.5) 13.6 (17.9) 12.1 (2.0) 11.3 (2.6) 0.797
  Insomnia Baseline 28.8 (30.0) 30.3 (28.9)    
3 months 24.1 (24.50 26.7 (26.9) 25.0 (2.1) 25.7 (3.1) 0.850
12 months 26.2 (27.9) 32.0 (27.2) 27.6 (2.5) 29.1 (3.4) 0.732
  Appetite loss Baseline 12.8 (20.9) 15.4 (24.8)    
3 months 10.7 (17.6) 17.3 (23.6) 11.3 (1.8) 17.7 (2.6) 0.048
12 months 11.6 (17.6) 13.6 (20.3) 12.1 (2.0) 13.7 (2.6) 0.631
  Constipation Baseline 16.9 (26.7) 18.9 (24.1)    
3 months 14.7 (23.3) 16.3 (21.6) 16.5 (1.8) 16.0 (2.7) 0.882
12 months 12.6 (18.1) 17.7 (20.5) 19.5 (2.2) 16.5 (2.9) 0.414
  Diarrhea Baseline 13.8 (20.7) 11.4 (18.8)    
3 months 12.6 (18.1) 14.0 (17.9) 19.8 (4.1) 10.0 (5.4) 0.151
12 months 20.5 (45.6) 9.5 (20.4) 11.9 (1.5) 15.3 (2.2) 0.211
  Financial Difficulties Baseline 20.3 (28.6) 23.4 (26.0)    
3 months 15.5 (25.5) 26.8 (37.1) 17.4 (2.6) 27.0 (3.7) 0.036 **
12 months 18.9 (26.6) 20.4 (27.9) 18.9 (2.5) 19.3 (3.3) 0.920
  The MOS-SSS Baseline 65.6 (20.9) 65.6 (20.6)    
3 months 66.3 (21.1) 67.9 (19.3) 66.9 (1.4) 65.7 (2.0) 0.621
12 months 66.6 (21.1) 68.0 (19.7) 67.1 (1.7) 65.3 (2.4) 0.535
  Health Behavior Baseline 4.9 (3.1) 5.2 (2.7)    
3 months 6.4 (2.7) 5.5 (3.0) 6.9 (0.3) 6.2 (0.4) 0.147
12 months 7.0 (2.8) 6.3 (2.7) 6.3 (0.2) 5.3 (0.3) 0.015**
  IES-R Baseline 2.3 (0.8) 2.5 (0.7)    
3 months 2.2 (0.7) 2.2 (0.7) 2.3 (0.1) 2.2 (0.1) 0.759
12 months 2.1 (0.7) 2.3 (0.8) 2.1 (0.1) 2.3 (0.1) 0.068 *
  1. aAdjusted baseline value with a statistical power of 80% and an effect size of 0.3 by a two-sided t test at the 0.05 α level was used
  2. *p < 0.10 with bold
  3. **p < 0.05 with bold
  4. 1)ANCOVA
  5. MET Metabolic Equivalent Task, PTGI Post-traumatic Growth Inventory, HADS Hospital and Anxiety Scale, EROTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30, MOS-SSS Medical Outcomes Study Social Support Survey, IES-R Impact of Event Scale--Revised